|
Volumn 505, Issue 7482, 2014, Pages 130-140
|
Leaked files slam stem-cell therapy
a
a
NONE
|
Author keywords
[No Author keywords available]
|
Indexed keywords
CELL THERAPY;
CLINICAL PROTOCOL;
GOOD MANUFACTURING PRACTICE;
HUMAN;
MESENCHYMAL STEM CELL;
MUSCULAR DYSTROPHY;
NOTE;
PARKINSON DISEASE;
PATIENT SAFETY;
PRIORITY JOURNAL;
STEM CELL TRANSPLANTATION;
THERAPY EFFECT;
CHILD;
CLINICAL TRIAL (TOPIC);
CONFIDENTIALITY;
CYTOLOGY;
ETHICS;
ITALY;
LEGAL ASPECT;
MESENCHYMAL STROMA CELL;
NEURAL STEM CELL;
NON PROFIT ORGANIZATION;
REPRODUCIBILITY;
STANDARD;
TRANSPLANTATION;
UNCERTAINTY;
CHILD;
CLINICAL TRIALS AS TOPIC;
CONFIDENTIALITY;
FOUNDATIONS;
HUMANS;
ITALY;
MESENCHYMAL STROMAL CELLS;
NEURAL STEM CELLS;
REPRODUCIBILITY OF RESULTS;
STEM CELL TRANSPLANTATION;
UNCERTAINTY;
|
EID: 84892159223
PISSN: 00280836
EISSN: 14764687
Source Type: Journal
DOI: 10.1038/505139a Document Type: Note |
Times cited : (11)
|
References (0)
|